Skip to content

Eli Lilly LLY Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin83%+1.7pp81.3%+2.1pp79.2%+2.5pp76.8%+2.6pp
Net margin31.7%+8.2pp23.5%+8.2pp15.4%-6.5pp21.9%+2.2pp
EBITDA margin42.5%+10.5pp32.1%+8.4pp23.7%-5.5pp29.2%+2.0pp
Free cash flow margin13.8%+5.4pp8.3%20.1%-1.3pp
Returns
Return on equity101.2%+16.6pp84.6%+35.6pp48.9%-14.7pp63.6%-12.7pp
Return on assets21.6%+6.8pp14.8%+5.6pp9.2%-3.5pp12.7%+1.0pp
Return on invested capital38.3%+11.8pp26.4%+8.9pp17.5%-8.4pp25.9%-0.7pp
Efficiency
Asset turnover0.7×+0.1×0.6×0.0×0.6×0.0×0.6×0.0×
Inventory turnover-0.2×1.3×-0.1×1.4×-0.2×1.6×-0.2×
Liquidity
Current ratio1.6×+0.4×1.2×+0.2×0.9×-0.1×1.1×-0.2×
Quick ratio1.2×+0.3×0.9×+0.2×0.7×-0.1×0.8×-0.2×
Cash ratio0.2×+0.1×0.1×0.0×0.1×0.0×0.1×-0.1×
Leverage
Debt-to-equity1.6×-0.8×2.4×0.0×2.4×+0.9×1.6×-0.4×
Debt-to-assets0.4×-0.1×0.4×0.0×0.4×+0.1×0.3×0.0×
Net debt / EBITDA1.3×-0.9×2.2×-0.7×2.9×+1.1×1.8×0.0×
Per Share
Book value per share$29.51+86.9%$15.79+32.4%$11.93+1.3%$11.77+19.5%
Valuation
Market capitalization$961.86B+38.5%$694.27B+25.5%$553.41B+59.2%$347.61B+31.6%
Enterprise value$997.32B+37.4%$725.79B+25.8%$576.93B+59.1%$362.51B+30.4%
Price / earnings46.6×-19.0×65.6×-40.1×105.6×+49.9×55.7×+8.3×
Price / sales14.8×-0.7×15.4×-0.8×16.2×+4.0×12.2×+2.8×
Price / book36.2×-12.4×48.6×-2.7×51.4×+18.7×32.6×+3.2×
EV / EBITDA36×-14.3×50.2×-21.2×71.4×+27.9×43.5×+7.4×
EV / sales15.3×-0.8×16.1×-0.8×16.9×+4.2×12.7×+2.9×
Free cash flow yield0.9%+0.4pp0.5%1.6%-0.6pp
Earnings yield2.1%+0.6pp1.5%+0.6pp0.9%-0.8pp1.8%-0.3pp
Dividend yield0.6%-0.1pp0.7%-0.1pp0.7%-0.3pp1%-0.2pp
PEG ratio0.5×-0.2×0.6×4.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Eli Lilly's ratios come from?
Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.